ADORA2A and neoplasm: Recent studies have highlighted that A2AR expression is significantly correlated with HIF-1α, CD73, CD8, and Foxp3, and that blocking A2AR significantly reduces the number of CD4+Foxp3+ Tregs while enhancing CD8+ T cell anti-tumor responses(Figure 3) (50).